Markus Lundgren
11 – 20 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes
- Contribution to journal › Article
-
Mark
Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes
- Contribution to journal › Article
-
Mark
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
- Contribution to journal › Article
-
Mark
Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles
- Contribution to journal › Article
-
Mark
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes : A secondary analysis of the POInT Study
- Contribution to journal › Article
-
Mark
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
- Contribution to journal › Article
-
Mark
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
- Contribution to journal › Article
- 2023
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
- Contribution to journal › Article
-
Mark
Refining the Definition of Stage 1 Type 1 Diabetes : An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
- Contribution to journal › Article
-
Mark
Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance : the TEDDY study
- Contribution to journal › Article
